论文部分内容阅读
目的:探讨蒲地蓝消炎口服液治疗疱疹性咽峡炎的临床疗效。方法:将78例疱疹性咽峡炎患儿,随机分为两组,其中治疗组40例,对照组38例。治疗组用口服蒲地蓝消炎口服液加对症治疗,对照组用口服利巴韦林颗粒加对症治疗。结果:治疗组总有效率95.0%,对照组总有效率76.3%,两组比较,差异有统计学意义(P<0.05)。结论:蒲地蓝消炎口服液治疗疱疹性咽峡炎疗效明显优于利巴韦林颗粒。
Objective: To investigate the clinical efficacy of Po Di Lan Xiaoyan oral liquid in the treatment of herpes angina. Methods: 78 cases of herpes simplex angina were randomly divided into two groups, including 40 cases in the treatment group and 38 cases in the control group. The treatment group with oral pomalin anti-inflammatory oral solution plus symptomatic treatment, the control group with oral ribavirin particles plus symptomatic treatment. Results: The total effective rate was 95.0% in the treatment group and 76.3% in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Po Di Lan anti-inflammatory oral herpetic acid treatment of angina significantly better than ribavirin particles.